Figure Captions
Figure 1. Study design diagram
Figure 2. Least square means and corresponding standard error
of dopamine (A), epinephrine (B), norepinephrine (C), normetanephrine
(D), homovanillic acid (E), and vanillylmandelic acid (F) 24-hour urine
excretion profiles
Figure 3. Percentage (arithmetic mean) of plasmatic inhibition
of DβH activity at pre-dose (trough) following administration of
zamicastat 400 mg (once daily) and placebo (PP-PD population, n=21).
(DβH: dopamine-β-hydroxylase; PP-PD: per-protocol pharmacodynamics)